Cell ablation technology is useful for studying specific cell lineages in a developing organ in vivo. Herein, we established a novel anti-Mü llerian hormone (AMH)-toxin receptor-mediated cell knockout (Treck) mouse line, in which the diphtheria toxin (DT) receptor was specifically activated in Sertoli and granulosa cells in postnatal testes and ovaries respectively. In the postnatal testes of Amh-Treck transgenic (Tg) male mice, DT injection induced a specific loss of the Sertoli cells in a dose-dependent manner, as well as the specific degeneration of granulosa cells in the primary and secondary follicles caused by DT injection in Tg females. In the testes with depletion of Sertoli cell, germ cells appeared to survive for only several days after DT treatment and rapidly underwent cell degeneration, which led to the accumulation of a large amount of cell debris within the seminiferous tubules by day 10 after DT treatment. Transplantation of exogenous healthy Sertoli cells following DT treatment rescued the germ cell loss in the transplantation sites of the seminiferous epithelia, leading to a partial recovery of the spermatogenesis. These results provide not only in vivo evidence of the crucial role of Sertoli cells in the maintenance of germ cells, but also show that the Amh-Treck Tg line is a useful in vivo model of the function of the supporting cell lineage in developing mammalian gonads.
Introduction
In mammalian embryos at early organogenic stages, undifferentiated genital ridges start to develop into the testis or ovary dependent on their genetic sex. As the first morphological sign of testis differentiation, germ cells are surrounded by differentiating Sertoli cells, leading to the formation of testis cords (future seminiferous tubules), a tubular structure of the germ and Sertoli cells packed within the basal lamina sheath (Harikae et al. 2013a , Svingen & Koopman 2013 . In developing ovaries, both germ and pre-granulosa cells also aggregate to form the poorly defined ovarian cords (ovigerous cord), subsequently resulting in the formation of ovarian cysts, a closed sack-like structure of several oocytes and their surrounding pre-granulosa cells (Pepling 2006 , Hummitzsch et al. 2013 . After birth, the testis cords develop into the seminiferous tubules associated with active spermatogenesis, while in the ovary the ovarian cyst breaks down into each individual primordial follicle, an oocyte surrounded by a single layer of granulosa cells. A part of the primordial follicle continuously grows into primary and subsequent secondary follicle stages at the medullary side during the initial round of folliculogenesis (Mork et al. 2012 , Harikae et al. 2013b .
From the fetal to adult stages, both Sertoli and granulosa cells secrete various growth factors to support the proliferation, differentiation and maintenance of the germ cells (Matsui 1998 , Choi & Rajkovic 2006 , Buratini & Price 2011 , Zhang et al. 2011 , Feng et al. 2014 . Moreover, the germ cells physically contact and interact intimately with the supporting cells inside the basal lamina sheath. These histological and physiological findings indicate the crucial roles of the gonadal supporting cells in the maintenance and survival of germ cells in mammalian gonads. However, the duration for which the germ cells are maintained after the specific loss of supporting cells in vivo remains unclear.
A conditional in vivo depletion of lineage-specific cells can be achieved through administration of diphtheria toxin (DT) to toxin-receptor-mediated cellknockout (Treck)-transgenic (Tg) mice that carry a human DT receptor (DTR; HBEGF-mut) cDNA transgene driven by a cell linage-specific promoter (Saito et al. 2001) . In this Treck system, the administration of DT to the Treck Tg mice causes depletion in only DTR-expressing cell linages and specifically eliminates these target cells in vivo (Takada et al. 2008 , Matsuoka et al. 2013 .
In mice, anti-Mü llerian hormone (Amh) is expressed specifically in the gonadal-supporting cell lineages: Sertoli and granulosa cells of postnatal immature gonads in both males and females (Lécureuil et al. 2002) . Herein, we established three Amh-Treck Tg lines carrying the Amh-promoter-fused DTR cassette, in which conditional in vivo deletion of the gonadalsupporting cells was induced by DT injection at postnatal timepoints. Here we show a great potential in the Amh-Treck line as an in vivo functional assay system of the supporting cell lineage in mammalian gonads.
Materials and methods

Amh-Treck Tg mouse line
The Amh-Treck transgene was prepared by inserting the entire 5 0 -flanking promoter region of the Amh gene (Guerrier et al. 1990 ) upstream of DT receptor (DTR; I117V/L148V mutant of human HB-EGF tagged with EGFP; Furukawa et al. 2006) . We successfully established three Amh-Treck Tg lines (#36, #85, #94) with testis-specific expression of DTR in male pups (Supplementary Figure S1 , see section on supplementary data given at the end of this article). The C57BL/6-Tg (CAG-EGFP) mice (GFP mice; SLC) and C57BL/6-R26-H2B-mCherry knockin mice (Cherry mice; Abe et al. 2011) were used as transplant donors for the rescue experiment. The ICR and C57BL/6 male mice (E12.5-10 weeks old; SLC) were also used for the immunohistochemical analyses. The animal experiments were carried out in accordance with the Guidelines for Animal Use and Experimentation of the University of Tokyo (approval IDs: P12-660 and P12-764).
Quantitative RT-PCR
Total RNA was reverse-transcribed using random primer with a Superscript-III cDNA Synthesis Kit (Invitrogen). PCR was carried out using an Applied Biosystems Step-One Real-Time PCR System with the primers and probes of Egfp (Mr04329676_mr) and Gapdh (Taqman control reagents).
DT treatment
Amh-Treck Tg mice (P3-21) were treated with DT (SigmaAldrich, 0.04-40.0 mg/kg, i.p.) as described previously (Saito et al. 2001 , Takada et al. 2008 , Matsuoka et al. 2013 ).
All tissues were subjected to histological and immunohistochemical analyses as described below.
Transplantation of EGFP or Cherry-positive Sertoli cells
A single-cell suspension (including gonocytes and Sertoli cells) (1.0!10 8 cells/ml) was prepared from the testes of 1-week-old GFP/Cherry mice (C57BL6) by a two-step enzymatic digestion procedure (Shinohara et al. 2003) , and then transplanted into the testes of 3-week-old recipient Tg males pre-treated with DT (0.4-4.0 mg/kg). On days 10 and 45 after transplantation, all recipient Tg testes were removed from the tunica albuginea and roughly dissected in cold PBS under an Olympus fluorescence microscope (BX51N-34-FL2) and stereomicroscope (SZX16 plus U-LH100HG) (Nagai et al. 2012) . The tissues were processed using the immunohistochemical techniques described below.
Histology and immunohistochemistry
The tissues were fixed in 4% paraformaldehyde (PFA) or Bouin's solution and routinely embedded in paraffin. The sections (4 mm thickness) were subjected to conventional histological (hematoxylin and eosin; H&E) and immunohistochemical staining as described previously (Hiramatsu et al. 2010 , Harikae et al. 2013b .
In brief, for immunohistochemical staining, the sections were incubated with anti-AMH (1:100 dilution; sc-6886; Santa Cruz), anti-3b-HSD (1:2000 dilution; sc-30821; Santa Cruz), antiCherry (1:200 dilution; ab125096; Abcam, Cambridge, United Kingdom), anti-E-cadherin (1:500 dilution; 610181; BD-Pharmingen, Franklin Lakes, NJ, USA), anti-FOXL2 (1:200 dilution; Uda et al. (2004) ; 1:200 dilution, ab5096; Abcam), anti-GATA4 (1:250 dilution; sc-1237; Santa Cruz), anti-GFP (1:200 dilution; 598; MBL, Nagoya, Japan), anti-GFRa1 (1:100 dilution; AF560; R&D Systems, Minneapolis, MN, USA), anti-HuB/Elavl2 (1:1000 dilution; H1538; Sigma), anti-laminin (1:400 dilution; 10765; ICN Pharmaceuticals, Santa Ana, CA, USA), anti-MVH/ DDX4 (1:5000 dilution; Toyooka et al. (2000) ; 1:1000 dilution; ab13840; Abcam), anti-PLZF (1:500 dilution; OP128, Calbiochem, Darmstadt, Germany), anti-a-smooth muscle actin (anti-SMA; 1:5000 dilution, A2547; Sigma), or anti-SOX9 (1:250 dilution; Kidokoro et al. (2005) ) antibody at 4 8C for 12 h. The reaction was visualized using a biotin-conjugated secondary antibody in combination with the Elite ABC Kit (Vector Laboratories) or by secondary antibodies conjugated with Alexa-488/594. TUNEL assays were also performed by using the Apoptotic Detection Kit (MK500; TaKaRa, Shiga, Japan).
Results and discussion
Establishment of Amh-Treck Tg mouse lines
The transgene was constructed as the Amh promoterdriven DT receptor (DTR; HBEGF-mut) (I117V/L148V mutant of human HB-EGF) tagged with EGFP (Furukawa et al. 2006; Fig. 1A) . We obtained three Tg lines (healthy and fertile in both sexes) by pronuclear injection of the plasmid-based transgene into the C57BL6 background. In Wt mice, endogenous Amh expression is found in the 1997) . In the ovary, Amh expression is defined in the growing follicles after P3 and later stages (Lécureuil et al. 2002) . The preliminary experiments carried out with DT treatment (4.0 mg/kg; Matsuoka et al. 2013) in the postnatal testes at P3-P10 showed degeneration in the majority of Sertoli cells in all of the three lines as well as no appreciable defects in other organs ( Fig. 1 and Supplementary Figure S3 ). Among these three lines, the EGFPtagged DTR expression was, although fluorescent signals are very weak, detectable in the seminiferous tubules and the primordial follicles of the testes and ovaries in the #94 line (Supplementary Figure S4) , in addition to the gonadspecific high-level expression of the DTR transgene by qPCR (Supplementary Figure S1) . Moreover, even a lowdose DT treatment (0.04 mg/kg) can affect the nuclear shape of Sertoli cells and their arrangement in the #94 line (see Fig. 1B ), and thus we used mainly the #94 line for subsequent experiments.
DT injection induces Sertoli cell degeneration in postnatal testes of Tg males in a dose-dependent manner
First, we examined the dose-dependent effects of DT on the Sertoli cell degeneration in the Amh-Treck line. The Tg males and their Wt littermates at P21 (post-weaning) were treated with DT at various dosages, from 0.04 to 40.0 mg/kg, and their organs including testes were histopathologically examined on day 4 after DT treatment ( Fig. 1B and Supplementary Figure S5 , see section on supplementary data given at the end of this article).
In the Tg males treated with 0.04 mg/kg DT, most of Sox9-positive Sertoli cells appeared morphologically healthy but the nucleus position was arranged irregularly in the seminiferous epithelia as compared with the nontreated control testes (Fig. 1B) . DT treatment at either 0.4 or 4.0 mg/kg clearly induced the loss of the Sox9-positive Sertoli cells in the seminiferous tubules by day 4 after DT treatment (Fig. 1B) . In contrast, no appreciable defects were found in the Wt mice treated with DTat 4.0-40 mg/kg (Supplementary Figure S5) . In addition, no gross-anatomical and histological defects were observed in the other organs of both Wt and Tg males treated with 4.0-40 mg/kg DT (Supplementary Figure S5 ; data not shown). Next, we examined the temporal changes in the testicular phenotype in DT-treated Tg testes (4.0 mg/kg) between days 1 and 10 after DT treatment (Fig. 1C) . On day 1, DT treatment showed onset of Sertoli cell degeneration; however, histological loss of the nucleus was observed on day 4 after DT treatment. Moreover, histological analysis revealed that the germ cells appeared to undergo germ cell degeneration with visible accumulation of cell debris at the luminal side on day 4. Finally, by day 10 after DT treatment, all Sertoli and germ cells were degenerated in the seminiferous tubules and consequently, a large amount of cell debris had accumulated inside the seminiferous tubules (Fig. 1C) . TUNEL staining also confirmed the appearance of apoptotic cell death in the germ cells at luminal side by day 4 after DT treatment (lower plates in Fig. 1C ; Supplementary Figure S6 , see section on supplementary data given at the end of this article). Anti-GFRa1 and anti-HuB immunostaining revealed that the GFRa1C undifferentiated spermatogonia (including spermatogenic stem cells; Sato et al. 2011) and HuBC differentiated spermatogonia (including pre-leptotene spermatocytes; Supplementary Figure S7) are detectable in the basal compartment of the seminiferous tubules on day 4 after DT treatment. However, both spermatogonial populations were depleted by day 10 after DT treatment (Fig. 1D ). These findings, therefore, confirmed that loss of Sertoli cells led to rapid cell death of germ cells within several days. This is consistent with previous reports involving Sertoli cell-specific deletion of Wt1 (Gao et al. 
Sertoli cell-specific loss of the seminiferous tubules in DT-treated Tg testes at P3 and P21
The specificity of the cell depletion in DT-treated testes was examined on day 4 after DT treatment. The male Tg pups and their Wt littermates at P3 and P21 were treated with DT (4.0 mg/kg) and the expression patterns of various somatic cell markers were examined immunohistochemically ( Fig. 2A) . In P3 testes treated with DT (upper plates in Fig. 2B ), the almost complete depletion of the Amh-positive or Sox9-positive Sertoli cells was found throughout the entire testis area. This is in sharp contrast with E-cad-positive rete testis epithelia, which appeared histologically normal (Fig. 2B) . Immunohistochemical analyses of P21 testes on day 4 after DT treatment also confirmed that GATA4-positive cells appeared intact in the peritubular and interstitial regions. However, no GATA4-positive signals were detectable in the seminiferous epithelia, leading to MVH-positive germ cells occupying the inside of the tubules (Fig. 2C) . The laminin-positive basal lamina, SMA-positive pertibular myoid cells, and 3b-HSDpositive Leydig cells appeared intact in the interstitial region (Fig. 2C) . The complete degeneration of cells inside the tubules by day 10 after DT treatment indicates that Sertoli cell-specific depletion occurs by day 4; germ cells then undergo rapid degeneration, which may result in the accumulation of a large amount of cell debris at the luminal side by day 10 after DT treatment.
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Transplantation of healthy immature Sertoli cells can rescue the germ cell degeneration in DT-treated Tg testes, leading to a partial recovery of the spermatogenesis
The intratubular injection method of the cell suspension prepared from immature testes previously showed that immature dividing Sertoli cells selectively colonize and support the recipient-derived spermatogenesis in the empty seminiferous tubules pre-treated with the Buslfan and cadmium (Shinohara et al. 2003) . In order to rescue the germ cell degeneration, healthy immature Sertoli cells (around P7) labeled by cytoplasmic/nuclear EGFP (CAG-EGFP) or nuclear Cherry (R26-H2B-mCherry) were transplanted (i.e. intratubular injection) in P21 Tg males, on day 4 after DT treatment (0.4-4.0 mg/kg). The transplanted testes were examined on day 10 after Sertoli cell transplantation (Fig. 3A) . In the DT-treated Tg testes transplanted with exogenous healthy testis cells, the transplantation sites were visualized by means of EGFPor Cherry-positive signals under a dissecting microscope (number of testes with donor cells per total testes injected: 10/18 testes (EGFP, 4/8 testes; Cherry, 6/10 testes); Fig. 3B ). Histological analysis revealed that a majority of transplanted cells were positive for Sox9, a Sertoli cell marker, suggesting selective settlement of the exogenous healthy Sertoli cells inside the DT-treated seminiferous tubules (Fig. 3D) . Moreover, exogenous healthy Sertoli cells were shown to maintain both endogenous and exogenous spermatogenic cells at the transplantation sites (Fig. 3C , D, E, and F). In some areas, the transplanted Sertoli cells had replaced the degenerated Sertoli cells and contributed to supporting the hostderived germ cells on day 10 (most right plates in Fig. 3D and F). Next, we examine the phenotypes of the DT-treated Tg testes on day 45 after the Sertoli cell transplantation. In one sample (Cherry, 1/3 testes), the transplanted Sertoli cells were observed to survive in the DT-treated testes (Fig. 3B , G, and Supplementary Figure  S8 , see section on supplementary data given at the end of this article). Moreover, in some areas, it was shown that the transplanted Sertoli cells partially restore spermatogenesis of endogenous spermatogenic cells on day 45 after the transplantation ( Fig. 3H and Supplementary Figure S8 ). These findings show that the transplanted immature Sertoli cells could replace some degenerated Sertoli cells and rescue in part the germ cell degeneration, albeit locally, in DT-treated Tg testes. These data also suggest this AMH-Treck system is useful for transplantation studies in terms of evaluating Sertoli cell function. Indeed, this new Treck system is more simple and effective than the previous method of the Sertoli cell transplantation, which used an intratubular injection of cadmium to deplete Sertoli cells (Shinohara et al. 2003) .
DT treatment allows the loss of granulosa cells under high-dose DT treatment in postnatal ovaries
Finally, we examined the phenotype of DT-induced cell depletion in the initial round of folliculogenesis in the Tg females at P7 (on day 4 after DT treatment at P3). Since the preliminary experiments using DT treatment at 4.0 mg/kg resulted in no appreciable histological defects in the developing ovaries (data not shown), we applied DT treatment (40.0 mg/kg) to the Tg ovaries; the phenotype was examined histopathologically on day 4 or day 25 after DT injection at P3 (Fig. 4) . A high-dose DT treatment induced almost complete loss of the AMH-positive follicles in the centromedullary region of the ovaries ( Fig. 4A and B) . At this DT concentration, both histological and immunohistochemical analyses confirmed the lack of granulosa cells around the growing oocyte in the majority of presumptive primary and secondary follicles ( Fig. 4B and C). The FOXL2-positive presumptive theca cells were found in the ovarian interstitium around the growing follicles. Both laminin-positive basal lamina and SMApositive perifollicular cells appeared intact and were directly connected to the growing oocyte with a diameter similar to those of the primary and secondary follicle stages (Fig. 4C) . No appreciable defects were detected in the ovaries of the littermates treated with DT at the same dose ('Wt' in Fig. 4B and C) . The absence of any histological abnormality in the ovarian-surface primordial follicle pool of the same DT-treated ovaries (Fig. 4B ) indicated a specific loss of the granulosa cells in growing follicles. Moreover, this suggested that the sensitivity to DT treatment of the granulosa cells of female pups was lower than that of the Sertoli cells of male pups in this Amh-Treck line. On day 30 after DT treatment (40 mg/kg), the DT-treated ovaries displayed a recovery of folliculogenesis in the cortex region, although the ovary size and the 3b-HSD-positive interstitial region appeared to be reduced (Fig. 4D) . The DT-treated ovaries contained many healthy Amh-positive primordial and secondary follicles (the plate farthest to the right in Fig. 4D ), suggesting new recruitment of primary and secondary follicles in these DT-treated ovaries. This was also consistent with the absence of any appreciable defects in the primordial follicle pool after the high-dose DT treatment.
In conclusion, we have established a novel Treck system that permits the specific loss of gonadal supporting cells at the postnatal stages using DT treatment. The present data confirm the essential role of Sertoli cells in germ cell survival in vivo. This model system is also useful not only for in vivo analyses of structural and endocrine roles of the supporting cell lineage at the postnatal stages, but also potentially for the in vivo functional assay of defective supporting cells in stem cell niche and spermatogenesis.
